Amryt Pharma plc Analysis
| Analyst Ratings |
|
Average Target Price
|
23.43
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.02
|
0.00
|
0.02
|
100.00%
|
|
2022-12-31
|
-0.04
|
0.00
|
0.04
|
100.00%
|
|
2022-09-30
|
-0.05
|
-0.06
|
-0.01
|
-20.00%
|
|
2022-06-30
|
-0.06
|
-0.10
|
-0.04
|
-66.67%
|
|
2022-03-31
|
-0.02
|
-0.25
|
-0.23
|
-1150.00%
|
|
2021-12-31
|
-0.12
|
0.80
|
0.92
|
766.67%
|
|
2021-09-30
|
-0.17
|
-0.07
|
0.10
|
58.82%
|
|
2021-06-30
|
0.05
|
-0.04
|
-0.09
|
-180.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.41
|
|
2021-12-31
|
0.60
|
|
2020-12-31
|
-2.45
|